![Xiao Lin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xiao Lin
Direttore/Membro del Consiglio presso Beijing Falikang Pharmaceutical Co. Ltd.
Posizioni attive di Xiao Lin
Società | Posizione | Inizio | Fine |
---|---|---|---|
Beijing Falikang Pharmaceutical Co. Ltd.
![]() Beijing Falikang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of FibroGen, Inc., Beijing Falikang Pharmaceutical Co. Ltd. is a pharmaceutical company that manufactures pharmaceutical products. Beijing Falikang Pharmaceutical Co. Ltd. is based in Beijing, China. Beijing Falikang Pharmaceutical Co. was acquired by FibroGen (China) Medical Technology Development Co. Ltd. on July 31, 2020 for $2.14 million. The Chinese company was founded in 2019. | Direttore/Membro del Consiglio | 27/09/2020 | - |
Storia della carriera di Xiao Lin
Statistiche
Distribuzione geografica
Cina | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Beijing Falikang Pharmaceutical Co. Ltd.
![]() Beijing Falikang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of FibroGen, Inc., Beijing Falikang Pharmaceutical Co. Ltd. is a pharmaceutical company that manufactures pharmaceutical products. Beijing Falikang Pharmaceutical Co. Ltd. is based in Beijing, China. Beijing Falikang Pharmaceutical Co. was acquired by FibroGen (China) Medical Technology Development Co. Ltd. on July 31, 2020 for $2.14 million. The Chinese company was founded in 2019. | Health Technology |
- Borsa valori
- Insiders
- Xiao Lin
- Esperienza